Showing Results for: “diabetes exercise”

Strategic collaboration formed to raise awareness that all people with diabetes on blood glucose-lowering medications should have glucagon, preferable a ready-to-use formulation The American Diabetes Association ® (ADA) and Xeris Pharmaceuticals ® (Xeris BioPharma Holdings, Inc.), a national supporter of the ADA, are pleased to announce a multi-year strategic partnership to reinforce the importance of prescribing glucagon, preferably ready-to-use, for all individuals with diabetes who are treated with insulin and/or insulin secretagogues or those at high risk of hypoglycemia (low blood glucose

On April 3, 2025, North Dakota became the 27th state to pass a law to lower patient cost-sharing limits for insulin in state-regulated health insurance plans. In response to Governor Armstrong signing HB 1114, Matt Prokop, state government affairs director at the American Diabetes Association® (ADA), issued the following statement: “The American Diabetes Association commends North Dakota policymakers for the passage of HB 1114, which limits cost sharing for insulin and certain related supplies at $25 for a 30-day supply for those on state employee health insurance plans and state-regulated

Regular physical activity is an important part of managing diabetes or dealing with prediabetes. Find what you need to know, from getting started to maintaining momentum.

Every generation on my mom's side has/had type 2 diabetes. It's unreal how people don't understand the damage diabetes can do to your body. It can affect almost every organ. My mom had glaucoma, retinopathy, needed a kidney transplant, and had portions of her foot amputated. My mom passed when she was 53 due to complications with diabetes. Past relatives also had amputations of the feet and legs. I just didn't realize the extent of the damage from diabetes until I was diagnosed. I am using what my family members went through to monitor my health. It's been rough, but I am trying. I take 15

Data Addresses Gaps in Preventive Prescriptions Therapy, Emphasizing the Importance of Multifaceted Interventions Today, findings from the COORDINATE-Diabetes trial demonstrated that multi-disciplinary care between cardiologists, diabetes specialists and other team members can significantly increase the prescriptions of evidence-based therapies to help treat patients with both type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD), commonly known as heart disease. The trial was presented as a late-breaking symposium today at the 83rd Scientific Sessions of the American

Reality show style competition showcases novel diabetes business ideas with potential funders as part of ADA 83 rd Scientific Sessions Today, the American Diabetes Association® (ADA) announced the winners of its inaugural pitch competition at the 83rd Scientific Sessions of the American Diabetes Association (ADA) in San Diego, CA. The first-ever Innovation Challenge highlighted six business concepts for diabetes care before a panel of potential funders, with the goal of connecting innovators and startup companies with transformative solutions and ideas. The winners, Minutia, Oregon Health &

American Diabetes Association Symposium Demonstrates Benefits of Once Weekly Drug for Weight Loss and Glycemic Control Today, findings from SURMOUNT-2, a study of tirzepatide in participants with type 2 diabetes who have obesity were announced, demonstrating more weight loss in individuals with diabetes than any other medication to date. The results were presented at the 83rd Scientific Sessions of the American Diabetes Association ® (ADA) in San Diego, CA and were simultaneously published in The Lancet . Obesity impacts 650 million people worldwide including nearly half of all Americans and

First-of-Its-Kind Study Compares Open-Source Automated Insulin Delivery to Sensor-Augmented Pump Therapy Results from the CREATE Trial demonstrated open-source automated insulin delivery (AID) systems are a safe and effective therapy for people with type 1 diabetes. Findings from the randomized controlled trial (RCT) comparing open-source AID to sensor-augmented pump therapy (SAPT) were presented today at the 82nd Scientific Sessions of the American Diabetes Association ® (ADA). Open-source AID systems were developed to reduce the burden of living with diabetes by combining an insulin pump

The American Diabetes Association® (ADA) applauds Alabama Governor Kay Ivey today for signing House Bill 249, legislation that will cap insulin co-sharing at $100 per month for those on state-regulated health plans, without regard to the policy deductible, and regardless of the quantity or type of insulin needed to fill the insured patient's prescription. Bill sponsor, Representative Paul Lee, Chairman of the House Health Committee and Senator Tom Butler, Chairman of the Senate Veteran’s and Military Affairs Committee provided leadership on this important legislation to reduce the burden of